In cancer cells undergoing ICD, type I interferons (IFN-Is) are released by mechanisms involving the detection of endogenous nucleic acids [28], i.e., dsRNA by TLR3 [71], or dsDNA by cyclic GMP-AMP synthase (cGAS) [72]. The gene discussed is CGAS; the disease is cancer.